Porcine Vaccines Market Know About Growth Rate, Trends, Segmentation and Key Players |MRFR

 

Porcine Vaccines Market Highlights

Porcine vaccines aid the swine or hogs suffering from epidemic swine diseases. It also helps in improving overall efficiency in protecting swine from deadly viruses, bacteria and increases the production level of high-quality meat and gelatine. The increasing prevalence of swine diseases such as PED (Porcine Epidemic Diarrhea), PRRS (Porcine Reproductive & Respiratory Syndrome), swine influenza etc. are anticipated to drive the market growth during the forecast period.  Additionally, rising number of biotechnology companies, research institutions engaged in research and development of porcine vaccines, and government initiatives for funding agriculture and animal husbandry sector and increasing demand for porcine meal and gelatine are likely to contribute to the market growth. For instance, by the world by per-capita pig meat consumption, US has an average of 64.4 kilos of meat consumed in 2017. According to National Pork Producers Council the pork production has an estimated USD 23.4 billion of gross output nationwide. However, high cost of maintaining vaccines may hamper the market growth during the assessment period.

The porcine vaccine market is estimated to grow crucially over the expected period. The porcine vaccines market had a market value of USD 2,429.76 Million in 2030 and is expected to grow at CAGR of 7.20% over 2022 to 2030.

Segmentation

The global porcine vaccines market has been segmented into type, disease indication, and end user.

By type, the market has been segmented into Inactivated vaccines, Live attenuated vaccines, Toxoid vaccines, Recombinant vaccines, Conjugate vaccines, DNA vaccines.

Based on disease indication, the global porcine vaccines market has been segmented into PED (Porcine Epidemic Diarrhea), PRRS (Porcine Reproductive & Respiratory Syndrome), Swine influenza, Aujeszky's disease (AD), Porcine Circovirus Associated Disease (PCVAD) and others.

The global porcine vaccines market, by end user, has been segmented into Veterinary Hospitals and Hog Production Farm.

Regional Analysis

On regional basis, the Americas is anticipated to dominate the global porcine vaccines market owing to the increasing prevalence of porcine diseases such as PED (Porcine Epidemic Diarrhea), PRRS (Porcine Reproductive & Respiratory Syndrome), swine influenza etc. and rapid increase in pig farms.  Additionally, rise in number of contract farming and independent farming for pig cultivation is contributing the market growth. According to The United States Department of Agriculture, National Agricultural Statistics Service “Livestock Slaughter” report, U.S. pork production was around 2 billion pound in 2016. Europe is expected to hold the second largest position in the global porcine vaccines market report owing to increasing number of production units for pigs and high consumption of pork meat. The Asia-Pacific region is anticipated to be fastest growing region is due to introduction of new vaccines, initiatives by various government agencies, animal care associations, and incidence of major key players for growth and development in this region. The Middle East & Africa has the least share of the global porcine vaccines market. Moreover, the major market share of the region is expected to be held by the Middle East region owing to the increasing government initiatives for the agriculture and animal husbandry sector.

Porcine Vaccines Market Players

The global porcine vaccines market players are Bayer AG, Bimeda, Inc., Boehringer Ingelheim International GmbH, Ceva Sante Animale, Eli Lilly and Company, Merck & Co., Inc., Sanofi S.A., Vetoquinol S.A., Zoetis, Inc., PBS Animal Health, Aptimmune.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 628 258 0071

Email: sales@marketresearchfuture.com

Comments

Post a Comment

Popular posts from this blog

Acute Care EHR Market Focuses on SWOT analysis, Synopsis, Development Plans 2020 to 2027

  Overview The acute care EHR slightly differ from the hospital and ambulatory EHR, generating patient information with all clinical details including the operating room, emergency department, ICU, and inpatient unit. Over the past decade, there has been a significant rise in the number of patients suffering from chronic diseases such as cancer, diabetes, heart disease, and stroke among others which are driving the acute care EHR market, increasing the number of caregiving facilities across the globe. Recognizing the exponential growth, the market perceives currently and gauging the potential the market holds to grow in the years to come; Market Research Future (MRFR), in its recently published market forecast asserts that the global  acute care EHR market  will grow exponentially by 2023, registering approximately 7% CAGR during the forecast period (2020 – 2027). The global acute care EHR is majorly driven by the augmenting demand for the remote health monitoring for geriatric patient
Read more

mHealth Market Latest Study Focuses On Current, Future Innovations and Top Key Vendors | Forecast 2030

  Market Overview The wave of modernization in the healthcare sector has led to the penetration of the concept of mHealth greatly. Reports that gauge the healthcare IT industry has been made available by Market Research Future which creates reports on several industry verticals that review the market growth and prospects. The market is forecasted to achieve a 36.5% CAGR in the upcoming forecast period. The robust growth pace in the wearable health device sector has increased the expansion of the  mHealth market  globally. Moreover, increased usage of smartphones is also playing a key role in the growth of the market. Also, patients are increasingly involved and aware of their treatments which is expected to further influence the mHealth market in the forecast period. Segmental Analysis The segmental evaluation of the mHealth market is carried out on the basis of therapeutics, applications, and region. On the basis of therapeutics, the mHealth market has been segmented into respiratory,
Read more

Cardiac Monitoring and Cardiac Rhythm Management Device Market Growth, Opportunity and Product Developments 2030 |MRFR

  Market Highlights The increasing demand for minimally invasive surgeries drives the growth of this market. Advanced technologies in cardiac monitoring and cardiac rhythm management devices have also led to growth in this market.  However, factors such as stringent regulatory approval procedures, the high cost of cardiac devices, and lack of reimbursement policies in developing countries are hindering the growth of the market. Rising prevalence of cardiovascular diseases and the increasing number of unmet medical needs in undeveloped countries are leading to the growth of the  cardiac monitoring and cardiac rhythm management device ma rket . Technical advancements in drug-eluting, MRI compatible pacemakers, and Holter monitors are some of the factors leading to the growth of this market. The growth of the global cardiac monitoring device market is driven by the high prevalence of cardiovascular disorders worldwide. Regional Analysis The market in the Americas is expected to dominate t
Read more